Tissue of Origin: B-cell / Plasma Cell
Cancer Type: B-cell Non-Hodgkin Lymphoma
SK-LY-18 is a human lymphoma cell line.
This cell line was established from a B-cell in a person with lymphoma
- Jorgen Fogh, PhD, formerly at Sloan Kettering Institute, Memorial Sloan Kettering
PubMed=6193516; DOI=10.1073/pnas.80.17.5397 Williamson B.D., Carswell E.A., Rubin B.Y., Prendergast J.S., Old L.J. Human tumor necrosis factor produced by human B-cell lines: synergistic cytotoxic interaction with human interferon.Proc. Natl. Acad. Sci. U.S.A. 80:5397-5401(1983)
This cell line may be licensed nonexclusively for research or commercial purposes.
For internal research purposes by a commercial entity: Utilize MSK’s Express License, attached here. In order to streamline and expedite the licensing of select MSK cell lines, the terms of this non-exclusive license are non-negotiable. Please note: This license is only available for select cell lines, including this one.
To proceed, please download this contract, fill in all relevant fields, and email a scanned version to [email protected]. Once this license has been executed by MSK, you will receive a signed copy and invoice, and can then place your order with ATCC.
For licensing requests for a commercial purpose: Contact MSK’s Tangible Materials team at [email protected].
For non-licensing requests from academic-research institutions: Contact Frances Weis-Garcia, PhD, Associate Laboratory Member/Head, Antibody & Bioresource Core Facility, MSK, 646-888-2354, [email protected].